荷兰随机对照研究显示预扩张自体脂肪移植长期比假体乳房再造更具成本效益
荷兰七中心随机对照研究将152例患者分配至预扩张自体脂肪移植(AFT)或假体乳房再造(IBR),比较术后12个月成本与EQ-5D-5L质量调整生命年(QALY)。AFT组QALY为0.83,IBR组为0.79;AFT术后12个月总成本高于IBR(增量成本€6763.59)。10年和30年敏感性分析显示平均增量成本分别为€2586.56和€680.22。作者认为AFT在10年和30年期间更具成本效益,但需更大队列确认长期结果。
要点
- AFT组术后12个月EQ-5D-5L QALY为0.83,IBR组为0.79。
- AFT术后12个月总成本高于IBR,增量成本为€6763.59。
- 10年和30年敏感性分析平均增量成本分别为€2586.56和€680.22。
核心结论
- AFT在再造术后第一年EQ-5D-5L QALY和成本均高于IBR;由于AFT组无需额外手术,估算其在10年和30年期间更具成本效益,但需更大队列确认。
研究设计与样本
- 荷兰七中心随机对照研究,2015年至2021年随机分配患者,比较AFT与IBR术后12个月的成本和EQ-5D-5L QALY。
- 共纳入152例女性,其中91例接受AFT(平均年龄49.3岁),80例接受IBR(平均年龄49.1岁)。
主要发现
- AFT组术后12个月平均EQ-5D-5L QALY为0.83,IBR组为0.79。
- AFT术后12个月总成本高于IBR,增量成本为€6763.59。
- 10年和30年敏感性分析显示平均增量成本分别为€2586.56和€680.22。
关键数值与推荐
- AFT组平均EQ-5D-5L QALY为0.83,IBR组为0.79。
- AFT术后12个月总成本较IBR增量成本为€6763.59。
- 10年敏感性分析平均增量成本为€2586.56,30年为€680.22。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需更大队列确认AFT长期更具成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: One in seven women will develop breast cancer, making it the most common female cancer worldwide. Consequently, breast cancer-related treatment, including breast reconstruction, impacts societal costs. Autologous fat transfer (AFT) is a relatively new breast reconstruction technique; however, several surgeries are necessary. This study investigates if AFT with pre-expansion is more cost-effective than implant-based reconstruction (IBR). METHODS: Seven centers assigned patients randomly from 2015 to 2021 to evaluate costs and EQ-5D-5L quality-adjusted life years (QALY) of AFT vs. IBR at 12 months postoperative. Costs were calculated, including direct costs related to treatment and PROductivity and DISease Questionnaire, to estimate productivity loss (indirect costs). Sensitivity analyses were performed for 10- and 30 years to estimate costs for patients replacing or explanting their breast implants over time. RESULTS: A total of 152 women, of which 91 received AFT (mean age 49.3) and 80 IBR (mean age 49.1). The mean EQ-5D-5L QALY in the AFT group was 0.83, compared with the IBR group of 0.79. Total costs for AFT at 12 months postoperative were higher than IBR (incremental cost: €6763.59). Sensitivity analyses for 10- and 30-year scenarios showed mean incremental costs of respectively €2586.56 and €680.22. CONCLUSION: Mean EQ-5D-5L QALY and costs were higher for AFT over the first year after reconstruction. However, these costs were low; therefore, AFT was estimated to be more cost-effective over the 10- and 30-year period since no additional surgeries are necessary for this group. Larger cohorts are required to confirm AFT is more cost-effective in the long term.
引用
- Wederfoort JLM, Voeten N, Smeins NNPM, et al. A Dutch randomized controlled study shows autologous fat transfer with pre-expansion is more cost-effective in the long term than implants. J Plast Reconstr Aesthet Surg. 2023. PMID: 37399660. doi:10.1016/j.bjps.2023.06.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。